Retrospective chart review investigating comparative efficacy between everolimus-based therapy versus endocrine monotherapy in post menopausal women with HR+/HER2- metastatic breast cancer
Latest Information Update: 05 Feb 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 05 Feb 2016 New trial record